637301-19-0 Usage
Uses
Used in Pharmaceutical Research:
Tert-butyl 8-oxo-3-azabicyclo[3.2.1]octane-3-carboxylate is utilized as a key intermediate in the synthesis of various pharmaceuticals and bioactive compounds. Its unique structure and reactivity allow for the development of new drug candidates with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, tert-butyl 8-oxo-3-azabicyclo[3.2.1]octane-3-carboxylate serves as a versatile building block. Its stability and functional groups enable the formation of diverse chemical structures, facilitating the discovery of novel compounds with potential applications in various industries.
Used in Drug Development:
Tert-butyl 8-oxo-3-azabicyclo[3.2.1]octane-3-carboxylate is employed as a precursor in the development of new drugs. Its unique structural features and reactivity make it a valuable component in the design and synthesis of innovative pharmaceutical agents, potentially leading to the discovery of more effective treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 637301-19-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,7,3,0 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 637301-19:
(8*6)+(7*3)+(6*7)+(5*3)+(4*0)+(3*1)+(2*1)+(1*9)=140
140 % 10 = 0
So 637301-19-0 is a valid CAS Registry Number.
637301-19-0Relevant articles and documents
METHOXY-SUBSTITUTED PYRROLOPYRIDINE MODULATORS OF RORC2 AND METHODS OF USE THEREOF
-
Page/Page column 63, (2016/08/23)
The present invention provides methoxy-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating RORγ activity and/or reducing the amount of IL- 17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.
INDAZOLE- AND PYRROLOPYRIDINE-DERIVATIVE AND PHARMACEUTICAL USE THEREOF
-
Page/Page column 207; 208, (2013/02/27)
The present invention relates to a novel indazole- or pyrrolopyridine-derivative, represented by the formula (1) below, that has an agonistic action or a partial agonistic action against serotonin-4 receptor, and a pharmaceutical composition comprising the same. Formula (1) [wherein each substituent is as defined in claim 1]